Annals of intensive care

Different daily body temperature patterns in severe muscle weakness during critical illness

Updated

Abstract

Essence

Critically ill patients with showed altered diurnal temperature rhythms and less suppression of rhythm amplitude during ICU stay than similar patients without myopathy.

Evidence

This secondary analysis of two prospective ICU trials compared 32 patients with critical illness myopathy, 30 without it, and 16 healthy bed-rest participants using cosinor analysis of body temperature rhythms.

Caveat

The study was small and hypothesis-generating, and the rhythm differences were correlational rather than proof that circadian disruption drives muscle catabolism.

Simplified

Key numbers

10:43
Shift
timepoint for patients compared to healthy bed rest group at 5:03.
0.3 °C
Temperature Rhythm
patients' compared to patients at 0.2 °C and healthy controls at 0.5 °C.
M. vastus lateralis
Cross-Sectional Area Correlation
Temperature rhythm correlated negatively with muscle fiber cross-sectional area.

Key figures

Fig. 1
Diurnal temperature rhythms in , , and healthy bed rest groups
Highlights higher temperature rhythm and phase shifts in CIM patients compared to no-CIM and healthy controls.
13613_2025_1582_Fig1_HTML
  • Panel a
    Healthy bed rest group shows physiological diurnal temperature rhythms with comparable rhythm patterns (blue lines).
  • Panel b
    CIM patients display phase-shifted temperature rhythms with maintained or higher amplitudes (green lines) and some comparable rhythms (blue lines).
  • Panel c
    No-CIM patients predominantly show lower amplitude temperature rhythms (red dotted lines) and some phase-shifted rhythms (green lines).
Fig. 2
vs : timing variability of temperature rhythm lows in ICU patients
Highlights high variability in temperature rhythm timing in critically ill patients, spotlighting circadian disruption in ICU settings
13613_2025_1582_Fig2_HTML
  • Panel a
    times on ICU day 5 for individual CIM (red) and no-CIM (blue) patients with arrows; group average indicated by bold vector; timing shows high variability without consistent
  • Panel b
    Temperature rhythm nadir times on ICU day 10 for CIM and no-CIM patients with individual arrows and group average vectors; variability remains high and phase direction inconsistent
  • Panel c
    Temperature rhythm nadir times aggregated over last 5 ICU days for CIM and no-CIM patients; arrows show individual variability and bold vectors show group averages without consistent phase direction
Fig. 3
Healthy bed rest vs vs : timing of lowest daily body temperature during ICU stay
Highlights a shifted timing of lowest body temperature in critically ill patients compared to healthy controls and stable timing within patient groups
13613_2025_1582_Fig3_HTML
  • Panel a
    Median time of temperature is earlier in healthy bed rest (around 05:03) than in CIM (10:43) and no-CIM (11:12) patients
  • Panel b
    Longitudinal median nadir times at ICU days 1-5, 6-10, and last 5 days show no clear difference between CIM and no-CIM groups
  • Panel c
    Relative effect of nadir timing over ICU stay shows no significant interaction or change between CIM and no-CIM groups
Fig. 4
Temperature rhythm values in healthy bed rest, , and ICU patients over time
Highlights a lower temperature rhythm mesor in CIM patients compared to no-CIM during ICU stay without significant temporal changes
13613_2025_1582_Fig4_HTML
  • Panel a
    Aggregated median mesor during ICU stay for healthy bed rest (36.8 °C), CIM (37.2 °C), and no-CIM (37.4 °C) groups with statistically lower mesor in CIM versus no-CIM
  • Panel b
    Longitudinal median mesor values at ICU days 1-5, 6-10, and last 5 days for CIM and no-CIM groups showing no clear difference between groups or significant change over time
  • Panel c
    Relative effects of mesor over time for CIM and no-CIM groups indicating no significant interaction between group and time
Fig. 5
Temperature rhythm in healthy bed rest, , and ICU patients
Highlights a less pronounced reduction in temperature rhythm amplitude in CIM patients compared to no-CIM during ICU stay
13613_2025_1582_Fig5_HTML
  • Panel a
    Median temperature rhythm amplitude during ICU stay for healthy bed rest, no-CIM, and CIM groups with statistical p-values; healthy bed rest shows highest amplitude, no-CIM lowest, CIM intermediate
  • Panel b
    Longitudinal median amplitude at ICU days 1-5, 6-10, and last 5 days for no-CIM and CIM groups; both groups show amplitude reduction over time
  • Panel c
    Relative effect of amplitude over ICU stay for no-CIM (dashed line) and CIM (solid line); no-CIM shows more pronounced amplitude reduction than CIM
1 / 5

Full Text

What this is

  • This analysis investigates diurnal temperature rhythms in critically ill patients with () compared to those without .
  • The study includes data from two prospective trials involving 62 patients classified as either (n = 32) or no- (n = 30).
  • Key findings reveal significant differences in temperature rhythm patterns, indicating potential circadian disruption related to critical illness.

Essence

  • patients exhibit distinct patterns compared to no- patients, with significant shifts in nadir timing and amplitude suppression during ICU stays. These findings suggest a disruption in circadian regulation that may contribute to muscle catabolism.

Key takeaways

  • patients show a temperature rhythm nadir at 10:43, shifted from the healthy bed rest group at 5:03. This shift indicates disrupted circadian rhythms due to critical illness.
  • Temperature rhythm amplitude is lower in both (0.3 °C) and no- (0.2 °C) patients compared to healthy controls (0.5 °C). The amplitude reduction is less pronounced in patients, suggesting a different adaptive response.
  • A higher temperature rhythm amplitude correlates negatively with muscle fiber cross-sectional area, indicating a potential link between circadian disruption and muscle atrophy in patients.

Caveats

  • The small sample size limits the generalizability of the findings. Further studies are needed to confirm these results and explore underlying mechanisms.
  • The retrospective nature of the analysis may introduce biases. Additionally, external factors in the ICU environment could influence temperature measurements.

Definitions

  • Critical illness myopathy (CIM): A condition characterized by muscle weakness and atrophy in critically ill patients, often leading to long-term disability.
  • Diurnal temperature rhythm: The natural fluctuation of body temperature over a 24-hour period, reflecting circadian regulation.

Simplified

Funding

Competing interests

Declarations. Ethics approval and consent to participate: The Charité Ethics Committee approved the clinical trials (EA2/061/06, EA2/041/10) and this secondary analysis (EA1/284/22 January 2023, amended 01 August 2024). Patients or legal proxies provided written informed consent prior to their inclusion to the study. Consent for publication: Patients or legal proxy were informed and consent was obtained for the anonymous publication of results. The manuscript does not contain identifiable persons´s data. Competing interests: The authors declare no competing interest related to the submitted work. Grants outside of the submitted work are reported by the following authors: JF was supported by the DFG (FI 965/9–1, FI 965/10–1) and the German Center for Cardiovascular Research, partner site Greifswald (DZHK 81Z5400153). FB (Balzer) received grants from DFG, Einstein Stiftung Berlin (Einstein Foundation Berlin), Gemeinsamer Bundesausschuss (Federal Joint Committee) and Koninklijke Philips N.V. FB (Balzer) received grants from or had contracts with BIH, Berlin University Alliance, Charité Foundation, German Federal Ministry of Education & Research, German Federal Ministry of Health, Hans Boeckler Foundation and Honda Research Institute during the last 36 months. FB received royalties or license fees from Elsevier, consulting fees from Medtronic, payments or honoraria for presentations or writings from GE and travel support from Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin and Robert-Koch-Institut. CS received grants from the German Research Society (DFG), Einstein Foundation Berlin Berlin, Federal Joint Committee, Federal Ministry of Education and Research (BMBF), Robert Koch Institute (RKI), Federal Ministry of Education and Research, the European Commission, Koninklijke Philips N.V. F. C, Dr. F. Köhler Chemie GmbH, Sintetica. CS discloses ownership of patent 15753 627.7 issued in Europe (Germany / Austria / Switzerland / Liechtenstein / France / United Kingdom / The Netherlands) as inventor, a U.S. patent PCT/EP 2015/067731 issued as inventor, a patent 3 174 588 issued in Europe (Germany /Switzerland / Liechtenstein / France / The Netherlands) as inventor, an international patent 10 2014 215 211.9 licensed, an international patent 10 2018 114 364.8 licensed, an international patent 10 2018 110 275.5 licensed, an international patent 50 2015 010 534.8 licensed, an international patent 50 2015 010 347.7 licensed, and an international patent 10 2014 215 212.7 licensed. CS discloses participation on a Data Safety Monitoring Board of Prothor and an advisory board of Lynx and Takeda Pharmaceutical Company Limited. CS discloses unpaid roles in Association of the Scientific Medical Societies in Germany AWMF), DFG review boards German National Academy of Sciences—Leopoldina, Berlin Medical Society, European Society of Intensive Care Medicine, European Society of Anaesthesiology and Intensive Care, German Society of Anaesthesiology and Intensive Care Medicine, German Interdisciplinary Association for Intensive care and Emergency Medicine, German Sepsis Foundation. SB reports salaried employment at Pfizer Pharma GmbH. Pfizer had no involvement in the conception, design, execution, or interpretation of the study, nor in the preparation or decision to submit the manuscript for publication.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free